Zobrazeno 1 - 10
of 73
pro vyhledávání: '"Peter Mohr"'
Autor:
Muhammad A. Khattak, Jason J. Luke, Georgina V. Long, Paolo A. Ascierto, Piotr Rutkowski, Dirk Schadendorf, Caroline Robert, Jean-Jacques Grob, Luis de la Cruz Merino, Michele Del Vecchio, Francesco Spagnolo, Jacek Mackiewicz, Vanna Chiarion-Sileni, Matteo S. Carlino, Peter Mohr, Federica De Galitiis, Merrick I. Ross, Zeynep Eroglu, Ke Chen, Ruixuan Jiang, Mizuho Fukunaga-Kalabis, Clemens Krepler, Alexander M.M. Eggermont, John M. Kirkwood
Publikováno v:
European Journal of Cancer. 176:207-217
Adjuvant pembrolizumab significantly improved recurrence-free survival (RFS) versus placebo in resected stage IIB and IIC melanoma in the phase 3 KEYNOTE-716 study. Health-related quality of life (HRQoL) results are reported.Patients were randomly as
Autor:
Elisabeth Livingstone, Lisa Zimmer, Jessica C Hassel, Michael Fluck, Thomas K Eigentler, Carmen Loquai, Sebastian Haferkamp, Ralf Gutzmer, Friedegund Meier, Peter Mohr, Axel Hauschild, Bastian Schilling, Christian Menzer, Felix Kiecker, Edgar Dippel, Alexander Roesch, Mirjana Ziemer, Beate Conrad, Silvia Körner, Christine Windemuth-Kieselbach, Leonora Schwarz, Claus Garbe, Jürgen C Becker, Dirk Schadendorf, Jan-Christoph Simon, Rudolf A Herbst, Carola Berking, Jochen Utikal, Sabine Sell, Uwe M Martens, Patrick Terheyden, Rudolf Stadler
Publikováno v:
The Lancet. 400:1117-1129
The IMMUNED trial previously showed significant improvements in recurrence-free survival for adjuvant nivolumab plus ipilimumab as well as for adjuvant nivolumab alone in patients with stage IV melanoma with no evidence of disease after resection or
Publikováno v:
SSRN Electronic Journal.
Autor:
Bart Neyns, Christian U. Blank, Michal Lotem, Mark R. Middleton, J.-J. Grob, Melanie A. Leiby, Antoni Ribas, C. Robert, Jacob Schachter, Céleste Lebbé, Euan Walpole, Matteo S. Carlino, Neil Steven, Nageatte Ibrahim, Peter Mohr, A. Arance, Paul Lorigan, Mario Sznol, Erin Jensen, Georgina V. Long, Laurent Mortier
Publikováno v:
Long, G V, Arance, A, Mortier, L, Lorigan, P, Blank, C, Mohr, P, Schachter, J, Grob, J-J, Lotem, M, Middleton, M R, Neyns, B, Steven, N, Ribas, A, Walpole, E, Carlino, M S, Lebbe, C, Sznol, M, Jensen, E, Leiby, M A, Ibrahim, N & Robert, C 2022, ' Antitumor activity of ipilimumab or BRAF ± MEK inhibition after pembrolizumab treatment in patients with advanced melanoma : analysis from KEYNOTE-006 ', Annals of oncology : official journal of the European Society for Medical Oncology, vol. 33, no. 2, pp. 204-215 . https://doi.org/10.1016/j.annonc.2021.10.010
Background: Antitumor activity of ipilimumab or BRAF +/- MEK inhibitors (BRAFi +/- MEKi) following pembrolizumab administration in melanoma is poorly characterized. Patients and methods: In the phase III KEYNOTE-006 study, patients with unresectable
Autor:
Michael Weichenthal, Patrick Terheyden, Edgar Dippel, Georg Lodde, Rudolf A. Herbst, Inga Möller, Lisa Zimmer, Dirk Schadendorf, Julia Kretz, Peter Mohr, Ralf Gutzmer, Jochen Utikal, Eleftheria Chorti, Johanna Matull, Claudia Pföhler, Annette Paschen, Luisa Richter, Anne Zaremba, Philipp Jansen, Friedegund Meier, Selma Ugurel, Carl M. Thielmann, Antje Sucker, Eva Hadaschik, Jens Ulrich, Klaus G. Griewank, Alexander Kreuter, Rajmohan Murali, Elisabeth Livingstone
Publikováno v:
Eur J Cancer
Background NF1-mutated tumours represent a small subset (10–15%) of melanomas, not sufficiently analysed in large clinical cohorts. This study investigated the largest multicentre collection of NF1-mutated melanomas to date. Methods This study anal
Autor:
Sarah Degenhardt, Marc Bender, I-Peng Chen, Stefan Henning, Mouna Mhamdi-Ghodbani, Christin Starzonek, Peter Mohr, Christoffer Gebhardt, Klaus Pantel, Beate Volkmer, Rüdiger Greinert
Publikováno v:
SSRN Electronic Journal.
Autor:
Georg Lodde, Philipp Jansen, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Claudia Pföhler, Jens Ulrich, Alexander Kreuter, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Edgar Dippel, Michael Weichenthal, Antje Sucker, Jan-Malte Placke, Anne Zaremba, Lea Jessica Albrecht, Bernd Kowall, Wolfgang Galetzka, Jürgen Becker, Alpaslan Tasdogan, Lisa Zimmer, Elisabeth Livingstone, Eva Hadaschik, Dirk Schadendorf, Selma Ugurel, Klaus Georg Griewank
Publikováno v:
SSRN Electronic Journal.
Publikováno v:
Annales de Dermatologie et de Vénéréologie - FMC. 1:A339-A340
Autor:
Peter Mohr, Martin Fochmann, James Alm, Nina E. Olson, Kay Blaufus, Erich Kirchler, Benno Torgler
Publikováno v:
SSRN Electronic Journal.
Governments have taken remarkable measures during the SARS-CoV-2 pandemic in their efforts to safeguard citizens’ health and the economy. As a consequence, public debts have reached unprecedented levels, which will require at some point higher taxe
Publikováno v:
SSRN Electronic Journal.
Increasing compliance is a vibrant topic in firms. Recent cases of loss of reputation and customer confidence have underlined the importance of this issue. A critical prerequisite for compliance on the firm level is compliance of the workforce. We ad